Ms. Clinton recently said that the drug companies were her “enemies.” Really? So why is she cashing all the giant checks from the drug companies then? She must really hate them, and they her. No way she’s throwing out soundbites to throw voters off of her donor scent. That isn’t like Hillary Clinton. She’d never do that.
You will recall that Nixon announced the first US government war on cancer. If the government really wants to cure cancer, it will remove the stifling FDA regulatory apparatus that makes progress glacial and any new treatments cost a fortune. The FDA operates on the principle that what is best for the drug industry is best for America, but the drug industry doesn’t make its biggest money from cures, it makes money from treatments for chronic conditions that are never cured.
But…But…But… I thought Hilary didn’t like the pharmaceutical companies. I thought they didn’t like her either. Hmmm.
When asked in the first Democratic presidential debate for an example of a political enemy, she named the drug companies. That was the word: “enemy.”
You’ve got to hand it to Obama in a weird way. He does a good job of placating his populist flank while his administration does the bidding of large corporations. Obamacare is one example, net neutrality is another, the TPP yet another.
One of the reasons we have generally opposed the Trans Pacific Partnership, even though we are big fans of international free trade, is because the agreement is likely chock full of crony deals. There’s a reason why so much secrecy surrounds the thing.
“Bought off” is perhaps too strong a phrase. Influenced in a big way? Yeah, that might be fair.
Unfortunately this team seems to be covering up a possible risk to black children.
Well done Ben. Great report.
In an earlier post we wondered why it is that we have what is essentially “medical heroin” (Oxycontin) in all 50 states, but medical marijuana – a far, far safer drug – in only a few states. We argued that Big Pharma had a lot to do with it. A recent report from VICE supports this hypothesis.
This is a move against Canadian pharmacies (primarily) which offer high quality drugs for sale at much lower prices than what is found in the USA.
Some hospitals which serve struggling areas have long qualified for the program which forces drug makers to sell their products at steep discounts. This was supposed to reward the hospitals for providing needed services. Since the patients, and their insurance companies are charged full price, this program, the 340B drug subsidy program, is a sweet deal for the hospitals.
There have long been efforts to pull the supplement industry more under the control of the FDA. (And in all likelihood crush it.)